Selective growth of epithelial basal cells from human prostate in a three-dimensional organ culture

Prostate

Volumn 59, Issue 4, 2004, Pages 383-392

  Papini, Sandra ^a,b   Rosellini, Alfredo ^a,b   Campani, Daniela ^c   DeMatteis, Anna ^a   Selli, Cesare ^c   Revoltella, Roberto Paolo ^a  

^a CNR   (Italy)

^b Farmigea SpA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Androgen sensitivity; Dihydrotestosterone; Human prostate; Stem cells; Stromal epithelial interactions; Three dimensional cultures

Indexed keywords

ANDROSTANOLONE; TESTOSTERONE;

ANIMAL CELL; ARTICLE; BASAL CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL HYPERPLASIA; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE EPITHELIUM; SECRETORY CELL;

CELL DIFFERENTIATION; CELL DIVISION; DIHYDROTESTOSTERONE; EPITHELIAL CELLS; HUMANS; MALE; ORGAN CULTURE TECHNIQUES; PROSTATE;

EID: 2442694030     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20021     Document Type: Article

References (57)

1. Isaacs JT. Development and characteristics of the available animal model systems for the study of prostatic cancer. Prog Clin Biol Res 1987;239:513-576.
2. Kyprianou N, Isaacs JT. Biological significance of measurable androgen levels in the rat ventral prostate following castration. Prostate 1987;10:313-324.
3. Bonkhoff H, Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model. Prostate 1996;28:98-106.
4. McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol 1968;49:347-357.
5. Di Sant'Agnese PA. Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 1992;23:287-296.
6. Di Sant'Agnese PA, Cockett AT. Neuroendocrine differentiation in prostatic malignancy. Cancer 1996;78:357-361.
7. Bonkhoff H. Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status. Prostate Suppl 1998;8:18-22.
8. Cress AE, Rabinovitz I, Zhu W, Nagle RB. The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev 1995;14:219-228.
9. Chung LW, Davies R. Prostate epithelial differentiation is dictated by surrounding stroma. Mol Biol Rep 1996;23:13-19.
10. Murant SJ, Handley J, Stower M, Reid N, Cussenot O, Maitland NJ. Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. Eur J Cancer 1997;33: 263-271.
11. Allsbrook WC Jr., Pfeifer EA. Histochemistry of the prostate. In: Foster CS, Bostwick DG, editors. Pathology of the prostate. Philadelphia, PA: Saunders; 1998. pp 282-303.
12. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996;29:117-134.
13. Nagle RB, Brawer MK, Kittelson J, Clark V. Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Am J Pathol 1991;138:119-128.
14. Wernert N, Seitz G, Achtstatter T. Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma. Pathol Res Pract 1987;182:617-626.
15. Xue Y, Smedts F, Debruyne FM, De la Rosette JJ, Schalken JA. Identification of intermediate cell types by keratin expression in the developing human prostate. Prostate 1998; 34:292-301.
16. Liu AY. Expression of CD44 in prostate cancer cells. Cancer Lett 1994;76:63-69.
17. Foster CS, Dodson A, Karavana V, Smith PH, Ke Y. Prostatic stem cells. J Pathol 2002;197:551-565.
18. Bostwick DG. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer 1996;78:330-336.
19. Rivas CI, Vera JC, Delgado-Lopez F, Heaney ML, Guaiquil VH, Zhang RH, Scher HI, Concha II, Nualart F, Cordon-Cardo C, Golde DW. Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer. Blood 1998;91:1037-1043.
20. De Marzo AM, Nelson WG, Meeker AK, Coffey DS. Stem cell features of benign and malignant prostate epithelial cells. J Urol 1998;160:2381-2392.
21. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985-1992.
22. Foster CS, Ke Y. Stem cells in prostatic epithelia. Int J Exp Pathol 1997;78:311-329.
23. Bonkhoff H, Remberger K. Morphogenetic concepts of normal and abnormal growth in the human prostate. Virchows Arch 1998;433:195-202.
24. Devaraj LT, Bostwick DG. Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations. Am J Surg Pathol 1993;17:645-659.
25. English HF, Santen RJ, Isaacs JT. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987;11:229-242.
26. Verhagen AP, Aalders TW, Remaekers FC, Debruyne FM, Schalken JA. Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 1988;13:25-38.
27. Hayward SW, Del Buono R, Deshpande N, Hall PA. A functional model of adult human prostate epithelium. The role of androgens and stroma in architectural organization and the maintenance of differentiated secretory function. J Cell Sci 1992;102:361-372.
28. Bonkhoff H, Stein U, Remberger K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 1994;24:114-118.
29. Wang Y, Hayward S, Cao M, Thayer K, Cunha G. Cell differentiation lineage in the prostate. Differentiation 2001;68: 270-279.
30. Deshmukh N, Scotson J, Dodson AR, Smith PH, Ke Y, Foster CS. Differential expression of acidic and basic fibroblast growth factors in benign prostatic hyperplasia identified by immunohistochemistry. Br J Urol 1997;80:869-874.
31. De Matteis A, Guidi A, Di Paolo B, Franco G, Revoltella RP. Endothelin-1 in human prostatic carcinoma treated with androgen withdrawal: An immunohistochemical study. Cancer 2001;15(91):1933-1939.
32. Leu FJ, Engvall E, Damjanov I. Heterogeneity of basement membranes of the human genitourinary tract revealed by sequential immunofluorescence staining with monoclonal antibodies to laminin. J Histochem Cytochem 1986;34:483-489.
33. Sinha AA, Gleason DF, Wilson MJ, Staley NA, Furcht LT, Palm SL, Reddy PK, Sibley RK, Martinez-Hernandez A. Immunohistochemical localization of laminin in the basement membranes of normal, hyperplastic, and neoplastic human prostate. Prostate 1989;15:299-313.
34. Cunha GR. Growth factors as mediators of androgen action during male urogenital development. Prostate Suppl 1996;6: 22-25.
35. Pretlow TG, Yang B, Pretlow TP. Organ culture of benign, aging, and hyperplastic human prostate. Microsc Res Tech 1995;30: 271-281.
36. Maitland NJ, Macintosh CA, Hall J, Sharrard M, Quinn G, Lang S. In vitro models to study cellular differentiation and function in human prostate cancers. Radiat Res 2001;155:133-142.
37. Hanto DW, Hopt UT, Hoffman R, Simmons RL. Lymphocyte recruitment, regional blood flow, and vascular permeability at sites of allogeneic cellular interactions. J Immunol 1982;129: 2437-2443.
38. Chishima T, Yang M, Miyagi Y, Li L, Tan Y, Baranov E, Shimada H, Moossa AR, Penman S, Hoffman RM. Governing step of metastasis visualized in vitro. Proc Natl Acad Sci USA 1997;94: 11573-11576.
39. Dube JY, Chapdelaine P, Tremblay RR. Effect of testicular hormones on synthesis of soluble proteins by dog prostate slices. Can J Biochem Cell Biol 1983;61:756-763.
40. Farnsworth WE. Activities of the androgen-responsive receptor of the prostatic plasma membrane. Invest Urol 1977; 15:75-77.
41. Margolis L, Hatfill S, Chuaqui R, Vocke C, Emmert-Buck M, Linehan WM, Duray PH. Long-term organ culture of human prostate tissue in a NASA-designed rotating wall bioreactor. J Urol 1999;161:290-297.
42. Olbina G, Miljkovic D, Hoffman RM, Geller J. New sensitive discovery histoculture model for growth-inhibition studies in prostate cancer and BPH. Prostate 1998;37:126-129.
43. Varani J, Dame MK, Wojno K, Schuger L, Johnson KJ. Characteristics of nonmalignant and malignant human prostate in organ culture. Lab Invest 1999;79:723-731.
44. Parrish AR, Sallam K, Nyman DW, Orozco J, Cress AE, Dalkin BL, Nagle RB, Gandolfi AJ. Culturing precision-cut human prostate slices as an in vitro model of prostate pathobiology. Cell Biol Toxicol 2002;18:205-219.
45. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, Yang A, Montironi R, McKeon F, Loda M. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 2000;157:1769-1775.
46. Masaki T, Yanagisawa M, Goto K. Physiology and pharmacology of endothelins. Med Res Rev 1992;12:391-421.
47. Saita Y, Yazawa H, Koizumi T, Morita T, Tamura T, Takenaka T, Honda K. Mitogenic activity of endothelin on human cultured prostatic smooth muscle cells. Eur J Pharmacol 1998;349:123-128.
48. Mann A, Breuhahn K, Schirmacher P, Blessing M. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of Keratinocyte proliferation, granulation tissue formation, and vascularization. J Invest Dermatol. 2001;117:1382-1390.
49. Kyprianou N, English HF, Isaacs JT. Activation of a Ca2+-Mg2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate 1988;13(2):103-117.
50. Lavker RM, Sun TT. Epidermal stem cells. J Invest Dermatol 1983;81:121S-127S.
51. Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 1987;84:2302-2306.
52. Papini S, Cecchetti D, Campani D, Fitzgerald W, Grivel JC, Chen S, Margolis L, Revoltella RP. Isolation and clonal analysis of human epidermal keratinocyte stem cells in long-term culture. Stem Cells 2003;21:481-494.
53. Lang SH, Stark M, Collins A, Paul AB, Stower MJ, Maitland NJ. Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture. Cell Growth Differ 2001;12:631-640.
54. Chen SS, Revoltella RP, Papini S, Michelini M, Fitzgerald W, Zimmerberg J, Margolis L. Multilineage differentiation of rhesus monkey embryonic stem cells in three-dimensional culture systems. Stem Cells 2003;21:281-295.
55. Hirai Y, Lochter A, Galosy S, Koshida S, Niwa S, Bissell MJ. Epimorphin functions as a key morphoregulator for mammary epithelial cells. J Cell Biol 1998;140:159-169.
56. Hudson DL, O'Hare M, Watt FM, Masters JRW. Proliferative heterogeneity in the human prostate: Evidence for epithelial stem cells. Lab Invest 2000;80:1243-1250.
57. Beffy P, Rovero P, Di Bartolo V, Laricchia Robbio L, Dane A, Pegoraro S, Bertolero F, Revoltella RP. An immunodominant epitope in a functional domain near the N-terminus of human granulocyte-macrophage colony-stimulating factor identified by cross-reaction of synthetic peptides with neutralizing anti-protein and anti-peptide antibodies. Hybridoma 1994;13: 457-468.